Rosa Rodriguez-Monguio

Professional Title: 
Associate Professor and Health Policy & Management Program Head
Health Policy and Management
Campus Address: 
322 Arnold House

B.S. in Economics, University Carlos III, Madrid, Spain, 1994; Ph.D. in Health Economics, University of Barcelona, Spain, 2001

Area(s) of Specialization: 

Pharmaceutical Economics and Policy; Economic Evaluation of Health Services and Programs; Cost-effectiveness of Diabetes Education and Management Interventions; Mental Health Services Evaluation

Research Description: 

Rosa Rodriguez-Monguio PhD is an Associate Professor and Director of the Health Policy & Management Program at the University of Massachusetts, Amherst School of Public Health and Health Sciences. Through her research, Dr. Rodriguez-Monguio advances and applies a variety of quantitative methods to study equity in access to health care services and pharmaceuticals, and the efficiency in the provision of health care services and products. Dr. Rodriguez-Monguio 's current research interests are in the areas of cost-effectiveness of healthcare services and programs including community-based diabetes behavioral interventions, assessment of the Medicaid provisions and mental health services evaluation, and the safety of drugs and medical devices. Dr. Rodriguez-Monguio's research also examines the impact of intellectual property regulation, the FDA regulation and policy, and reimbursement mechanisms on pharmaceutical prices and utilization.

Key Publications: 

Rodriguez-Monguio R, Spielberger K, Seoane E. Examination of risk evaluation and mitigation strategies and drug safety in the US. Res Social Adm Pharm. 2014; 10(1):232-238

Jasinski CF, Rodriguez-Monguio R., Tonyushkina K, and Allen H. Healthcare cost of type 1 diabetes mellitus in new-onset children in a hospital compared to an outpatient setting. BMC Pediatrics, 2013; 13:55

Pellegrini LC, Rodriguez-Monguio R. Unemployment, Medicaid provisions, the mental health industry, and suicide. Social Science Journal. 2013;50(4):482-490.

Rodriguez-Monguio R, Seoane E. The Patent Life of Antiretroviral Drugs Approved by the FDA between 1987 and 2007. AIDS Care, 2009;21(6):760-768.

Seoane E, Rodriguez-Monguio R, Szeinbach SL, Visaria J. Incentives for Orphan Drug Research and Development in the United States. Orphanet Journal of Rare Diseases, 2008;3(33):1-7.